X, Y., L, X., C, B., D, D., L, C., X, Y., . . . K, S. (2018). Lactoferrin-modified rotigotine nanoparticles for enhanced nose-to-brain delivery: LESA-MS/MS-based drug biodistribution, pharmacodynamics, and neuroprotective effects. Dove Medical Press.
Cita Chicago Style (17a ed.)X, Yan, Xu L, Bi C, Duan D, Chu L, Yu X, Wu Z, Wang A, y Sun K. Lactoferrin-modified Rotigotine Nanoparticles for Enhanced Nose-to-brain Delivery: LESA-MS/MS-based Drug Biodistribution, Pharmacodynamics, and Neuroprotective Effects. Dove Medical Press, 2018.
Cita MLA (8a ed.)X, Yan, et al. Lactoferrin-modified Rotigotine Nanoparticles for Enhanced Nose-to-brain Delivery: LESA-MS/MS-based Drug Biodistribution, Pharmacodynamics, and Neuroprotective Effects. Dove Medical Press, 2018.